Lipocine
LPCN
LPCN
24 hedge funds and large institutions have $2.73M invested in Lipocine in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
24
Holding in Top 10
–
Calls
$28K
Puts
–
Top Buyers
| 1 | +$409K | |
| 2 | +$86.3K | |
| 3 | +$17K | |
| 4 |
BlackRock
New York
|
+$6.75K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3K |
Top Sellers
| 1 | -$613K | |
| 2 | -$341K | |
| 3 | -$132K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$83K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74K |